Physician
Geary, Meghan
Geary, Meghan was paid $618K by Medicaid between Mar 2018 and Dec 2024, across 34 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 25% of everything it billed.
33Billing provider infoGEARY, MEGHAN
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1073925988assigned 05/27/2014
33bProvider typeInternal Medicine Physician
28Total paid$618K
24GClaims9,570
24DCodes billed34
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Rhode Island
Rank by total paid#17 of 386
Median peer was paid$15K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,080 | $56K | |
| 2019 | 648 | $6K | |
| 2020 | 476 | $21K | |
| 2021 | 1,442 | $92K | |
| 2022 | 2,636 | $227K | |
| 2023 | 1,950 | $135K | |
| 2024incomplete | 1,338 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 25% | 3,221 | 2,926 | $154K |
| 36415 | Collection of venous blood by venipuncture | 8.0% | 1,157 | 970 | $49K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 496 | 467 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 519 | 480 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.4% | 619 | 571 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.3% | 1,124 | 1,027 | $27K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.9% | 138 | 131 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.8% | 129 | 124 | $24K |
| 86706 | 3.4% | 109 | 104 | $21K | |
| 87340 | 3.4% | 103 | 98 | $21K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.3% | 117 | 112 | $21K |
| 86803 | 3.2% | 134 | 128 | $20K |
22 more codes
| 86780 | 2.7% | 98 | $17K | |
| 86704 | 2.5% | 76 | $15K | |
| 87505 | 2.5% | 80 | $15K | |
| 86787 | 2.0% | 61 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 326 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 102 | $12K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.9% | 98 | $12K |
| 86708 | 1.4% | 46 | $9K | |
| 80061 | Lipid panel | 1.2% | 210 | $8K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 33 | $6K |
| 87209 | <1% | 43 | $6K | |
| 87177 | <1% | 43 | $6K | |
| 80053 | Comprehensive metabolic panel | <1% | 74 | $5K |
| 87631 | <1% | 15 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 57 | $3K |
| 81001 | <1% | 18 | $2K | |
| 96127 | <1% | 157 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $612.33 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 107 | $462.42 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 24 | $442.84 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 12 | $395.67 |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $284.82 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.